Advertisement

 

 

Quantitative analyses reveal distinct sensitivities of the capture of HIV-1 primary viruses and pseudoviruses to broadly neutralizing antibodies.

Quantitative analyses reveal distinct sensitivities of the capture of HIV-1 primary viruses and pseudoviruses to broadly neutralizing antibodies.
Author Information (click to view)

Kim J, Jobe O, Peachman KK, Michael NL, Robb ML, Rao M, Rao VB,


Kim J, Jobe O, Peachman KK, Michael NL, Robb ML, Rao M, Rao VB, (click to view)

Kim J, Jobe O, Peachman KK, Michael NL, Robb ML, Rao M, Rao VB,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

Virology 2017 05 31508() 188-198 pii 10.1016/j.virol.2017.05.015

Abstract

Development of vaccines capable of eliciting broadly neutralizing antibodies (bNAbs) is a key goal to controlling the global AIDS epidemic. To be effective, bNAbs must block the capture of HIV-1 to prevent viral acquisition and establishment of reservoirs. However, the role of bNAbs, particularly during initial exposure of primary viruses to host cells, has not been fully examined. Using a sensitive, quantitative, and high-throughput qRT-PCR assay, we found that primary viruses were captured by host cells and converted into a trypsin-resistant form in less than five minutes. We discovered, unexpectedly, that bNAbs did not block primary virus capture, although they inhibited the capture of pseudoviruses/IMCs and production of progeny viruses at 48h. Further, viruses escaped bNAb inhibition unless the bNAbs were present in the initial minutes of exposure of virus to host cells. These findings will have important implications for HIV-1 vaccine design and determination of vaccine efficacy.

Submit a Comment

Your email address will not be published. Required fields are marked *

15 + two =

[ HIDE/SHOW ]